← Evidence map

ArticleCancer management and research2022

Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for

Dan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36411743